[fcb5af]: / literature / by_gene / CD83.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 33620088 10.1111/bjh.17362 2021 Soluble PD-L1 is a promising disease biomarker but does not reflect tissue expression in classic Hodgkin lymphoma. CD83
2 33684939 10.1182/blood.2020007683 2021 Characterization of DLBCL with a PMBL gene expression signature. CD83
3 33945543 10.1371/journal.pone.0248886 2021 Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes. CD83
4 34173009 10.1007/s00262-021-02988-3 2021 The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells. CD83
5 32685149 10.1002/cti2.1156 2020 Targeting CD83 in mantle cell lymphoma with anti-human CD83 antibody. CD83
6 33139544 10.1073/pnas.2014470117 2020 Essential role of the linear ubiquitin chain assembly complex and TAK1 kinase in A20 mutant Hodgkin lymphoma. CD83
7 31075666 10.1016/j.anndiagpath.2019.04.009 2019 The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma. CD83
8 29351987 10.3324/haematol.2017.178384 2018 CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma. CD83
9 29572346 10.3324/haematol.2018.188870 2018 CD83 in Hodgkin lymphoma. CD83
10 29058460 10.1089/dna.2017.3923 2017 Ginsenoside Rg1 Activates Dendritic Cells and Acts as a Vaccine Adjuvant Inducing Protective Cellular Responses Against Lymphomas. CD83
11 25867364 10.4238/2015.March.27.3 2015 Stimulation of dendritic cell maturation and induction of apoptosis in lymphoma cells by a stable lectin from buckwheat seeds. CD83
12 26239360 10.3892/mmr.2015.4153 2015 Effect of thymosin α₁ on the phenotypic and functional maturation of dendritic cells from children with acute lymphoblastic leukemia. CD83
13 26573001 10.1309/AJCPUJGMVV6ZF4GG 2015 High levels of regulatory T cells in blood are a poor prognostic factor in patients with diffuse large B-cell lymphoma. CD83
14 24188174 10.1111/cei.12231 2014 Integrin-driven monocyte to dendritic cell conversion in modified extracorporeal photochemotherapy. CD83
15 24633193 10.1038/modpathol.2014.44 2014 A novel immunohistochemical classifier to distinguish Hodgkin lymphoma from ALK anaplastic large cell lymphoma. CD83
16 24714353 10.1097/CJI.0000000000000014 2014 Complementation of antigen-presenting cells to generate T lymphocytes with broad target specificity. CD83
17 25470820 10.1371/journal.pone.0114345 2014 Macrophages and dendritic cells as actors in the immune reaction of classical Hodgkin lymphoma. CD83
18 23737309 2013 Vaccination of diffuse large B- cell lymphoma patients with antigen-primed dendritic cells. CD83
19 23958949 10.1182/blood-2012-09-456988 2013 Denileukin diftitox (ONTAK) induces a tolerogenic phenotype in dendritic cells and stimulates survival of resting Treg. CD83
20 22615251 10.1128/IAI.00381-12 2012 Comparative analysis of the interaction of Helicobacter pylori with human dendritic cells, macrophages, and monocytes. CD83
21 22678564 10.2340/00015555-1220 2012 Distribution and maturation of skin dendritic cell subsets in two forms of cutaneous T-cell lymphoma: mycosis fungoides and Sézary syndrome. CD83
22 22739162 2012 [Anti-tumor immune response of dendritic cells derived from lymphoma cells transduced with recombinant adenovirus encoding human P53]. CD83
23 22740445 10.1182/blood-2012-03-415380 2012 Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas. CD83
24 20715107 10.1002/ijc.25597 2011 Specific infiltration of langerin-positive dendritic cells in EBV-infected tonsil, Hodgkin lymphoma and nasopharyngeal carcinoma. CD83
25 20980519 10.1128/JVI.01007-10 2011 Activation of plasmacytoid dendritic cells by Kaposi's sarcoma-associated herpesvirus. CD83
26 21479995 10.1007/s00262-011-1014-6 2011 The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice. CD83
27 21492747 10.1016/j.intimp.2011.03.022 2011 Preparation and identification of a novel immunomodulator composed of muramyl dipeptide and anti-CD10 monoclonal antibody for treatment of minimal residual disease in acute leukemia children. CD83
28 21668308 10.2217/imt.11.56 2011 Broad-spectrum immunosuppression by classless monocytes in non-Hodgkin's lymphoma. CD83
29 20420706 10.1186/1465-9921-11-45 2010 Cigarette smoke promotes dendritic cell accumulation in COPD; a Lung Tissue Research Consortium study. CD83
30 19129484 10.1189/jlb.0808469 2009 Histone deacetylase inhibition improves differentiation of dendritic cells from leukemic blasts of patients with TEL/AML1-positive acute lymphoblastic leukemia. CD83
31 20514853 2009 Dendritic cell distribution in lymphomas. CD83
32 18464117 10.1080/10428190802007734 2008 Expression profiling reveals specific gene expression signatures in gastric MALT lymphomas. CD83
33 18809238 10.1016/j.exphem.2008.07.003 2008 Costimulation molecule expression and subset distribution of blood dendritic cells in normal children and newly diagnosed pediatric leukemia and lymphoma patients. CD83
34 18991097 10.1080/08820130802403358 2008 Development of immunogenic tumor-loaded dendritic cells through physical perturbation and apoptotic cell loading. CD83
35 17212709 10.1111/j.1399-0039.2006.00706.x 2007 The expression analysis of ICOS-L on activated T cells and immature dendritic cells as well as malignant B cells and Grave's-disease-derived thyroid tissues by two novel mAbs against human ICOS-L. CD83
36 17285277 10.1007/s00277-007-0256-z 2007 Upregulation of antigen-processing machinery components at mRNA level in acute lymphoblastic leukemia cells after CD40 stimulation. CD83
37 17312329 10.1200/JCO.2006.09.3534 2007 Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias. CD83
38 17535098 10.2350/06-04-0082.1 2007 Anaplastic large cell lymphomas: a study of 75 pediatric patients. CD83
39 17598863 10.1111/j.1600-0781.2007.00285.x 2007 Clinical-scale generation of strongly CD83-expressing dendritic cells using extracorporeal photopheresis. CD83
40 17979570 10.1089/cbr.2007.356 2007 Human allogeneic and murine xenogeneic dendritic cells are cytotoxic to human tumor cells via two distinct pathways. CD83
41 16517754 10.4049/jimmunol.176.6.3830 2006 Sensitization of IL-2 signaling through TLR-7 enhances B lymphoma cell immunogenicity. CD83
42 16733557 2006 CD40 stimulation induces differentiation of acute lymphoblastic leukemia cells into dendritic cells. CD83
43 16830056 2006 Low expression of costimulatory molecules and mRNA for cytokines are important mechanisms of immunosuppression in acute lymphoblastic leukemia in children? CD83
44 17101562 10.1080/00365510600931098 2006 Acute lymphoblastic leukaemia cells express CCR7 but not higher amounts of IL-10 after CD40 ligation. CD83
45 15820064 2005 [In vitro inducing differentiation of bone marrow mononuclear cells of chronic myeloid leukemia]. CD83
46 16029505 10.1186/1476-8518-3-4 2005 Rapid construction of a dendritic cell vaccine through physical perturbation and apoptotic malignant T cell loading. CD83
47 14681701 10.1038/sj.gt.3302141 2004 Functional transfer of CD40L gene in human B-cell precursor ALL blasts by second-generation SIN lentivectors. CD83
48 14687618 10.1016/s0145-2126(03)00255-8 2004 The soluble form of CD83 is present at elevated levels in a number of hematological malignancies. CD83
49 15183897 10.1016/j.exphem.2004.03.004 2004 Adhesion capacity and integrin expression by dendritic-like cells generated from acute myeloid leukemia blasts by calcium ionophore treatment. CD83
50 15359643 10.1080/10428190310001653682 2004 Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy. CD83
51 11843292 10.1007/BF02981980 2002 The generation of immunocompetent dendritic cells from CD34+ acute myeloid or lymphoid leukemia cells. CD83
52 11904731 10.1007/s00262-001-0253-3 2002 Generation of functional dendritic cells for potential use in the treatment of acute lymphoblastic leukemia. CD83
53 12006212 10.1080/146532402317381875 2002 Immune escape mechanisms of childhood ALL and a potential countering role for DC-like leukemia cells. CD83
54 12408353 10.1080/0031302021000009469 2002 CD83 in Hodgkin and Reed-Sternberg cells. CD83
55 12452867 10.1046/j.1365-2133.2002.04994.x 2002 Dendritic cells and apoptosis in mycosis fungoides. CD83
56 11161986 10.1006/clim.2000.4968 2001 Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli. CD83
57 11372738 10.1007/BF02981944 2001 A Hodgkin's disease cell line, KM-H2, shows biphenotypic features of dendritic cells and B cells. CD83
58 11587218 10.1038/sj.leu.2402273 2001 An optimised biphasic culture system for the generation of functional dendritic cells from patients with acute lymphoblastic leukaemia at presentation and in clinical remission. CD83
59 11587221 10.1038/sj.leu.2402226 2001 CD20 antibody (C2B8)-induced apoptosis of lymphoma cells promotes phagocytosis by dendritic cells and cross-priming of CD8+ cytotoxic T cells. CD83
60 10698208 10.1097/00000372-200002000-00001 2000 Nonlymphoid intraepidermal mononuclear cell collections (pseudo-Pautrier abscesses): a morphologic and immunophenotypical characterization. CD83
61 11342340 10.3109/10428190009113387 2000 Increased cytotoxicity against B-chronic lymphocytic leukemia by cellular manipulations: potentials for therapeutic use. CD83
62 12042046 10.1080/146532400539099 2000 In vitro generation of dendritic cells derived from cryopreserved CD34+ cells mobilized into peripheral blood in lymphoma patients. CD83
63 12058165 2000 Expression of Human Soluble CD40 Ligand in Pichia pastoris and Its Effects on Dendritic Cells and Malignant B Cells. CD83
64 10467329 10.1038/sj.bmt.1701916 1999 Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high risk leukemia. CD83
65 10477734 1999 CD34(+) acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells. CD83
66 9643561 10.3109/10428199809050907 1998 Developmental aspects of dendritic cells in vitro and in vivo. CD83
67 9271021 10.1080/00313029700169125 1997 Hodgkin's cells express CD83, a dendritic cell lineage associated antigen. CD83
68 8075582 10.3109/10428199409052677 1994 New CD from the B cell section of the Fifth International Workshop on Human Leukocyte Differentiation Antigens. CD83